Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Anderson

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Journal of Neurosurgery|October 3, 1999
Valproate therapy for prevention of posttraumatic seizures: a randomized trialN R Temkin, S S Dikmen, G D Anderson, et al.
The Journal of Pediatrics|October 1, 1989
Indomethacin reduces the risks of severe intraventricular hemorrhageH S Bada, R S Green, M Pourcyrous, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Bidirectional interaction of valproate and lamotrigine in healthy subjectsG D Anderson, M K Yau, B E Gidal, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
The Journal of Pediatrics|July 1, 1990
Frequent handling in the neonatal intensive care unit and intraventricular hemorrhageH S Bada, S B Korones, E H Perry, et al.
Journal of Medicinal Chemistry|October 27, 1995
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, G D Anderson, E G Burton, et al.
Circulation|February 2, 2000
Upregulation of COX-2 during cardiac allograft rejectionX Yang, N Ma, M J Szabolcs, et al.
American Journal of Obstetrics and Gynecology|September 1, 1980
The use of medroxyprogesterone acetate for relief of climacteric symptomsJ C Morrison, D C Martin, R A Blair, et al.
Journal of Medicinal Chemistry|April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, M B Norton, E J Reinhard, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 22, 2013
Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?L Myatt, R G Clifton, J M Roberts, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Journal of Neurosurgery|October 3, 1999
Valproate therapy for prevention of posttraumatic seizures: a randomized trialN R Temkin, S S Dikmen, G D Anderson, et al.
The Journal of Pediatrics|October 1, 1989
Indomethacin reduces the risks of severe intraventricular hemorrhageH S Bada, R S Green, M Pourcyrous, et al.
Clinical Pharmacology and Therapeutics|August 1, 1996
Bidirectional interaction of valproate and lamotrigine in healthy subjectsG D Anderson, M K Yau, B E Gidal, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
The Journal of Pediatrics|July 1, 1990
Frequent handling in the neonatal intensive care unit and intraventricular hemorrhageH S Bada, S B Korones, E H Perry, et al.
Journal of Medicinal Chemistry|October 27, 1995
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, G D Anderson, E G Burton, et al.
Circulation|February 2, 2000
Upregulation of COX-2 during cardiac allograft rejectionX Yang, N Ma, M J Szabolcs, et al.
American Journal of Obstetrics and Gynecology|September 1, 1980
The use of medroxyprogesterone acetate for relief of climacteric symptomsJ C Morrison, D C Martin, R A Blair, et al.
Journal of Medicinal Chemistry|April 26, 1996
Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agentsJ J Li, M B Norton, E J Reinhard, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 22, 2013
Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?L Myatt, R G Clifton, J M Roberts, et al.
Pageof 17